Literature DB >> 12515380

Identification of cells deficient in signaling-induced alternative splicing by use of somatic cell genetics.

Paul Sheives1, Kristen W Lynch.   

Abstract

In recent years, a growing number of mammalian genes have been shown to undergo alternative splicing in response to extracellular stimuli. However, the factors and pathways involved in such signal-induced alternative splicing are almost entirely unknown. Here we describe a novel method for identifying candidate trans-acting factors that are involved in regulating mammalian alternative splicing, using the activation-induced alternative splicing of the human CD45 gene in T cells as a model system. We generated a cell line that stably expresses a CD45 minigene-based GFP reporter construct, such that the levels of green-fluorescent protein (GFP) expressed in the cell reflect the splicing state of the endogenous CD45 gene. Following mutagenesis of this cell line, and multiple rounds of selection for cells that displayed aberrant levels of GFP expression, we isolated several cell lines that are at least partially defective in their ability to support regulated alternative splicing of endogenous CD45 pre-mRNA in response to cell stimulation. Thus we have successfully isolated mutants in a mammalian alternative splicing pathway through use of a somatic cell-based genetic screen. This study clearly demonstrates the feasibility of using genetic screens to further our understanding of the regulation of mammalian splicing, particularly as it occurs in response to environmental cues.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12515380      PMCID: PMC1370353     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  38 in total

1.  A model system for activation-induced alternative splicing of CD45 pre-mRNA in T cells implicates protein kinase C and Ras.

Authors:  K W Lynch; A Weiss
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  A CaMK IV responsive RNA element mediates depolarization-induced alternative splicing of ion channels.

Authors:  J Xie; D L Black
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

Review 3.  Alternative pre-mRNA splicing: the logic of combinatorial control.

Authors:  C W Smith; J Valcárcel
Journal:  Trends Biochem Sci       Date:  2000-08       Impact factor: 13.807

Review 4.  Alternative RNA splicing in the nervous system.

Authors:  P J Grabowski; D L Black
Journal:  Prog Neurobiol       Date:  2001-10       Impact factor: 11.685

5.  A genomic view of alternative splicing.

Authors:  Barmak Modrek; Christopher Lee
Journal:  Nat Genet       Date:  2002-01       Impact factor: 38.330

6.  A point mutation in CD45 may be associated with an increased risk of HIV-1 infection.

Authors:  E Z Tchilian; D L Wallace; R Dawes; N Imami; C Burton; F Gotch; P C Beverley
Journal:  AIDS       Date:  2001-09-28       Impact factor: 4.177

7.  A point mutation in PTPRC is associated with the development of multiple sclerosis.

Authors:  M Jacobsen; D Schweer; A Ziegler; R Gaber; S Schock; R Schwinzer; K Wonigeit; R B Lindert; O Kantarci; J Schaefer-Klein; H I Schipper; W H Oertel; F Heidenreich; B G Weinshenker; N Sommer; B Hemmer
Journal:  Nat Genet       Date:  2000-12       Impact factor: 38.330

8.  Human genomic sequences that inhibit splicing.

Authors:  W G Fairbrother; L A Chasin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

9.  Insulin regulates alternative splicing of protein kinase C beta II through a phosphatidylinositol 3-kinase-dependent pathway involving the nuclear serine/arginine-rich splicing factor, SRp40, in skeletal muscle cells.

Authors:  N A Patel; C E Chalfant; J E Watson; J R Wyatt; N M Dean; D C Eichler; D R Cooper
Journal:  J Biol Chem       Date:  2001-03-30       Impact factor: 5.157

10.  An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity.

Authors:  R Majeti; Z Xu; T G Parslow; J L Olson; D I Daikh; N Killeen; A Weiss
Journal:  Cell       Date:  2000-12-22       Impact factor: 41.582

View more
  7 in total

1.  Visualization and genetic analysis of alternative splicing regulation in vivo using fluorescence reporters in transgenic Caenorhabditis elegans.

Authors:  Hidehito Kuroyanagi; Genta Ohno; Hiroaki Sakane; Hiroyuki Maruoka; Masatoshi Hagiwara
Journal:  Nat Protoc       Date:  2010-08-05       Impact factor: 13.491

2.  Identification of RNA-binding proteins that regulate FGFR2 splicing through the use of sensitive and specific dual color fluorescence minigene assays.

Authors:  Emily A Newman; Stephanie J Muh; Ruben H Hovhannisyan; Claude C Warzecha; Richard B Jones; Wallace L McKeehan; Russ P Carstens
Journal:  RNA       Date:  2006-04-07       Impact factor: 4.942

3.  Use of transcriptional synergy to augment sensitivity of a splicing reporter assay.

Authors:  Noah Levinson; Rochelle Hinman; Ashwini Patil; Corey R J Stephenson; Stefan Werner; Grace H C Woo; Jingbo Xiao; Peter Wipf; Kristen W Lynch
Journal:  RNA       Date:  2006-03-23       Impact factor: 4.942

4.  Imaging the alternative silencing of FGFR2 exon IIIb in vivo.

Authors:  Vivian I Bonano; Sebastian Oltean; Robert M Brazas; Mariano A Garcia-Blanco
Journal:  RNA       Date:  2006-10-26       Impact factor: 4.942

Review 5.  The impact of alternative splicing in vivo: mouse models show the way.

Authors:  Tarik Möröy; Florian Heyd
Journal:  RNA       Date:  2007-06-11       Impact factor: 4.942

6.  A cell-based screen for splicing regulators identifies hnRNP LL as a distinct signal-induced repressor of CD45 variable exon 4.

Authors:  Justin D Topp; Jason Jackson; Alexis A Melton; Kristen W Lynch
Journal:  RNA       Date:  2008-08-21       Impact factor: 4.942

7.  Identification of an exonic splicing silencer in exon 6A of the human VEGF gene.

Authors:  Rui Wang; Ronald G Crystal; Neil R Hackett
Journal:  BMC Mol Biol       Date:  2009-11-17       Impact factor: 2.946

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.